In May 2005, the Sales Force Effectiveness Conference
was held in the company of over 200 senior-level attendees.
“A real
learning and sharing opportunity with an unerlying
message that effectiveness, not incremental efficiencies
will deliver future success for Pharma.”
Ira Blake, Lilly |
“The
growth in the size of this SFE event indicates
its importance in the S&M calendar. Once again
the event matched expectations. Senior execs who
are serious about SFE should attend, and find out
how they can accelerate company performance.”
Martin Armstrong, Novartis
|
“Fewer
vendor presentations and more industry presentations
with interesting content. Very good improvements.”
Greg Miller, Novo Nordisk |
“It was
my first attendence at the event, I found it good
value and plan to attend future meetings.”
Neil Hartley, Trinity–Chiesi Pharmaceuticals |
“It was
useful, I want to be there at the next conference.”
Dunai Attila, Bayer |
“Very interesting
to hear about experiences (case studies) from colleagues
of other companies”
Sascha Mielcarek, Grünenthal |
“Highly
useful and educational in terms of getting other
professional perspectives on today's challenges in
Pharma Sales.”
Fabian Kaspereit, BackWeb Technologies |
“Good focal
point for bringing together the best minds, developments
and exoerience in the field of SFE”
Ian Pritchard, Innovex |
“Bigger and better than
ever.”
Rebecca Richards, StayinFront |
“Good mix
of information and networking”
Eric Saine, StratX |
Excellent forum for benchmarking.
Jan Olof Hesse, Schering-Plough |
“Ideal
for networking and to get a more global view of the
industry”
Patrick Goossens, Merck |
“Was inspired ... allowed
me to take new initiatives”
Jean-Marie De Maeseneer, Deloitte Consulting |
“This event
is essential to understanding how various pharma
companies are adddressing key indutry-wide Sales
Force Effectiveness issues.”
Lisa Lechner, Ascent Pharma Group |
“An eye-opener, motivating
you to go back home and address a few issues which
long needed addressing”
Wim Kockelkoren, Astellas |
“Very useful
for me”
Kokkosis Dionysis, Abbott |
“I am really surprised how
well this conference is organised”
Mato Papi, Pliva |
“Another
great event for learning and networking, high class
speakers and a good number of pharma attendees”
Jonathan Gardner, The Chalfont Project |
“Exceeded expectations with
good turnout from diverse companies and countries”
Hans-Erik Gording, Bang & Olufsen Medicom |
“Sales
Force Effectiveness will be the most important factor
in nearest future to be better than your competitors”
Pawe Pacholczyk, GlaxoSmithKline |
“Valuable. Good audience
of pharma delegates”
Lara Ciccarelli, Procter & Gamble |
“Good standard
of lectures and good calibre of delegates”
Richard Carruthers, In2Focus |
“Don't go to this conference
if you feel that you don't want more tasks to do,
because after all the input you WILL be busy!”
Per Hyllén, Leo Pharma |
“Overall,
the event met and surpassed my needs. Pace was great,
a good variety of topics discussed.”
Bill Bryan, Solvay Pharma |
“One of the best/informative/interactive
conferences I've been to in a while.”
Robert Volkommer, CSC Healthcare |
“Thought
the event itself was very worthwhile. Good depth/breadth
of subject matter and insights/issues.”
Jack Cartor, P&G |
“Good coverage of subject
matter relevant to sales force effectiveness. Thank
you. Relevance of topics, good mix of case studies,
and appropriate level of detail.”
Edward Kim, Lifescan |
“I was
pleased that I met so many new contacts. I will definitely
be exhibiting next year.”
Kerry Knee, JDP Med |
“I took away useful information
that will enhance my contribution to my company.”
Jim Fuhring, Amgen |
“This event
provided much more information and interaction than
I expected; I would consider this event a must-attend
for our company in the future… The topics were
all relevant; speakers were good; vendors were very
well positioned and not overly pushy; the duration
was perfect!”
Delegate From Serono |
“Event allowed me insight
to changing trends of our industry and the different "tools/theories" to
addressing these trends… It is always good
to get out and benchmark your practices with that
of the rest of the industry”
Anthony Gliozzo, McNeil Speciality Pharma |
“Good opportunity
to hear presentations from a variety of perspectives,
with a strong focus on actionable content.”
David Grossberg, Synygy |
“Good interaction of display
and customers.”
Larry Reister, Cegedim |
“I thought
the topic was relevant and the speakers all reinforced
each other. The flow of the presentation was correct… Convenient
location and diversity of speakers and topics.”
Eric Longino, Ortho-Mcneil |
“High level of professionalism
and courtesy in helping participants…I entered
a new world.”
Pietro Pontrelli, Sanofi Aventis |
“Overall,
it was very well organized, the level of presentations
was well above average.”
Roberto Ravagnani, EOS |
“Interesting learning experience
providing good insights into improvements into the
SFE process.”
Paul Monteiro. Janssen-Cilag Portugal |
“Knowing
that all companies are faced with the same issues,
it is interesting to share opinions and experiences
during an event like this one.”
Marcelino Duarte, Dendrite |
“Overall a great event,
good attendance from the industry and good venue.”
David D Macmurchy, PharmaPoint |
“A great
event - good opportunity to meet industry contacts
and hear interesting presentations on topical industry
issues.”
Alasdair Mackintosh, Cap Gemini |
“It was my first one and
I believe that if you follow the conference you are
getting a much more broader view than your country
and the discussions with individuals on breaks and
lunchtimes were really of value.”
Marc Mertens, AstraZeneca |
“It has
been fruitful allowing me to exchange views with
colleagues and catching new concepts for my daily
business.”
Joaquin Palacio, Roche |
“It was very interesting.
I have the opportunity to watch what kind of things
the others colleagues are doing in the others pharmaceutical
companies.”
Paulo Pinguelo, Grunenthal |
“All professional,
was brilliant.”
Peter Markotan, Boehringer Ingelheim |
“It was well organised,
well focused on the main topic.”
Peter Sandor, Schering |
“Overall
it was a very well organized conference.”
Richard Veraguth, Dendrite |
“For me personally, the
event was motivating because it was evident that
small and medium pharma is very close in SFE activities
to big pharma.”
Vesna Simanovic, Pliva |
“I liked
seeing the different views in the different companies
and the opportunities to meet and share views.”
Yannick Grecourt, Sanofi Aventis |
“Definitely becoming the
event of the calendar.”
Nina Felton, IMS Health |
